Thanks to everyone who attended Eyecelerator 2020!

Eyecelerator Overview

9:00 – 9:05 a.m. a.m.

David W. Parke II, MD, Steve Speares, Gil Kliman, MD, Vance Thompson, MD, Mark S. Blumenkranz MD

The 3C's: Impact of COVID, Capital Markets and Consolidation

8:05 – 9:05 a.m.

Top executive leads a sequence of multidisciplinary panel discussions that examine the key forces reshaping ophthalmic innovation. 

​

Moderator: Jim Mazzo

​

Panel 1:
Eric D. Donnenfeld, MD; Mark S. Humayun, MD, PhD; Jeffrey J. Kimbell, (Jeffrey J. Kimbell & Associates, Inc.); Jim Momtazee (Patient Square Capital)

Panel 2:
Larry Biegelsen (Wells Fargo); Mike Giaquinto (SVBLeerink); Gil Kliman, MD, (InterWest Partners); Elizabeth Yeu, MD

​

Innovations for Practice Recovery and Growth

9:05 – 10:05 a.m.

Rapidly accelerating advances in diagnostics, therapeutics, tele-health, patient flow.

​

Vance Thompson, MD; Ranya Habash, MD; Eduardo C. Alfonso, MD 

​

Mad Eye Money

10:05 – 10:28 a.m.

Strap in for a lightning round of market analysis and ideas for financing innovation.

​

Moderator: Gil Kliman, MD

Panelists: Jon Norris (Silicon Valley Bank); Brian Scullion (William Blair); Michael Lachman (EyeQ Research) 

​

Inside the Global Game, Pt. I

10:28 – 10:43 a.m.

The Academy's CEO sits down with executives from global health care giants to uncover key insights for advancing innovation partnerships. 

​

Moderator: David W. Parke II, MD
 

Strategic discussion with Johnson & Johnson Vision 

• Warren Foust, Worldwide President, Surgical Vision

• Raj Rajpal, MD, CMO, Global Head of Clinical and Medical Affairs

• Xiao-YuSong, MD, PhD, Global Head of Research & Development

​

Company Showcase I: Anterior Segment/Glaucoma

10:43 a.m.– 12:17 p.m.

Moderators: Lama A. Al Aswad, MD and Ranya Habash, MD

​

➢ Presbyopia/Myopia

1. LensGen

2. Visus Therapeutics

3. Yolia Health

4. SightGlass Vision, Inc.

➢ Cornea/Dry Eye

1. Aperta Biosciences

2. TearClear

3. SilkTech Biopharmaceuticals

4. Trefoil Therapeutics

5. EyeYon Medical

➢ Drug Delivery

1. Emmecell

2. AnkyrBio, LLC

3. Kedalion Therapeutics

➢ Devices and Sensors

1. Centricity Vision, Inc.

2. PreVista

3. Infinite Medical Ventures

4. Implandata Ophthalmic Products GmbH

5. Injectsense, Inc.

​

Inside the Global Game, Pt. II

12:17 – 12:32 p.m.

The Academy's CEO sits down with executives from global health care giants to uncover key insights for advancing innovation partnerships. 

​

Moderator: David W. Parke II, MD
 

Strategic discussion with Alcon

• Alan Landers, OD, MS, Head, Search & Evaluation BD&L Vision Care

• Shannon Spock, Surgical Search and Evaluation Head, Business Development and Licensing

• Costin Curatu, Head, Search and Evaluation, Surgical BD&L

​

Company Showcase II: Retina Secreted Factors, Genes, Devices

12:32 – 12:59 p.m.

Uncover key insights for advancing partnerships with industry giants.

​

Moderators: Mark Blumenkranz, MD and Allen Ho, MD

​

1. Neurotech Pharmaceuticals, Inc.

2. Aviceda Ophthalmics

3. Gensight Biologics

4. Notal Vision,Inc.

5. Pixium Vision

​

Opportunities & Challenges for Medium-Sized Companies

12:59 – 1:19 p.m.

Uncover key insights for advancing partnerships with industry giants.

​

Moderators: Allen Ho, MD and Sean Ianchulev, MD

​

Panelists: 

• Wiley Chambers, MD (FDA)

• Pravin Dugel, MD (Iveric Bio)

• Rick Eiswirth (Alimera Sciences)

• Cedric Francois, MD, PhD (Apellis)

• Hylton Kalvaria (Verana Health)

• Aaron Osborne (Adverum Biotech)

• Ram Palanki (RegenxBio)

​

Company Showcase III: Advancing Trials in the Public Eye

1:19  – 1:46 p.m.

Moderators: Mark Blumenkranz, MD and Allen Ho, MD 

​

1. AldeyraTherapeutics, Inc.

2. Kubota Vision

3. Ocular Therapeutix

4. Lineage Cell Therapeutics, Inc.

5. Verana Health

Inside the Global Game, Pt. III

1:46  – 2:01 p.m.

The Academy's CEO sits down with executives from global health care giants to uncover key insights for advancing innovation partnerships. 

​

Strategic discussion with Allergan, an AbbVie company

• Jag Dosanjh, Senior Vice President, Medical Therapeutics

• Michael R. Robinson, MD, Vice President, Global Therapeutic Area Head Ophthalmology

• Doug Faunce, PhD, Executive Director, Search and Evaluation-Eyecare Abbvie Corporate Strategy

​

Opportunities and Challenges for Large Companies

2:01  – 2:21 p.m.

Uncover key insights for advancing partnerships with industry giants.

​

Moderator: Mark Blumenkranz, MD

​

Panelists:

• Abu Abraham, MD (Santen)

• Anthony Adamis, MD (Genentech)

• Eddy Anglade, MD (Johnson & Johnson Vision/Janssen)

• Laurent Attias (Alcon)

• Andrew Gitkin (Raymond James)

• Chuck Hess (Bausch + Lomb)

• Angelo Rago (Zeiss)

• Dirk Sauer, PhD (Novartis)

• Jonathan Weyne, MD (Regeneron) 

​

Inside the Global Game, Pt. IV

2:21 – 2:36 p.m.

The Academy's CEO sits down with executives from global health care giants to uncover key insights for advancing innovation partnerships. 

​

Moderator: David W. Parke II, MD

Strategic discussion with Zeiss

• Euan S. Thomson, PhD, President 

• Steve Schallhorn, MD, Chief Medical Officer 

• Andy Chang, Head of Global Sales 

​

Rise of The Machines

2:36  – 3:36 p.m.

Robotics and brain-machine interfaces are still in their infancy but they have the potential to improve outcomes for ophthalmic patients by enabling digitally-driven therapies. Take a peek over the horizon at the emerging fields of robotics and brain machine interfaces with "the father of robotic surgery." 

​

Moderators: Ranya Habash, MD (BMI) and Gil Kliman, MD (Robotics)

Keynote – Fred Moll, MD
Chief Development Officer, Johnson & Johnson Medical Devices
Founder, Intuitive Surgical and Auris Health

Panelists: Dimitri Azar, MD, (Verily Life Sciences); Linda Lam MD, Associate Professor of Ophthalmology (USC Keck School of Medicine); Reza Zadno, CEO (Procept Biorobotics); Marc de Smet, MD, CMO (Preceyes); Doug Kelly, MD (FDA)

​

Cultivating Diversity in Innovation

3:36 – 4:21 p.m.

First-of-its-kind session explores the importance and measurable value of building a diverse community to advance new technology and treatments. 

​

Moderators: Lama A. Al-Aswad, MD, MPH and Deepinder K. Dhaliwal, MD, L.Ac

Keynote – The Mix That Matters: Innovation Through Diversity
Karin Schetelig, Principal, The Boston Consulting Group

Panelists: Caren Mason (STAAR Surgical); Jag Dosanjh (Allergan, an AbbVie company); Ramgopal Rao (LensGen, Inc.); Todd Pinkney (Centricity Vision)

​

Best of Show and Closing Remarks

4:21  – 4:30 p.m.

Eyecelerator Company Pick and and People's Choice Company Pick

​

Presented by Co-chairs Gil Kliman, MD, Mark Blumenkranz, MD, Vance Thompson, MD

​